182 related articles for article (PubMed ID: 21487072)
1. Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.
Berg KA; Rowan MP; Sanchez TA; Silva M; Patwardhan AM; Milam SB; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2011 Jul; 338(1):92-9. PubMed ID: 21487072
[TBL] [Abstract][Full Text] [Related]
2. Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.
Jamshidi RJ; Jacobs BA; Sullivan LC; Chavera TA; Saylor RM; Prisinzano TE; Clarke WP; Berg KA
J Pharmacol Exp Ther; 2015 Nov; 355(2):174-82. PubMed ID: 26297384
[TBL] [Abstract][Full Text] [Related]
3. Allosterism within
Jacobs BA; Pando MM; Jennings E; Chavera TA; Clarke WP; Berg KA
Mol Pharmacol; 2018 Apr; 93(4):376-386. PubMed ID: 29436492
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway.
Cunha TM; Souza GR; Domingues AC; Carreira EU; Lotufo CM; Funez MI; Verri WA; Cunha FQ; Ferreira SH
Mol Pain; 2012 Feb; 8():10. PubMed ID: 22316281
[TBL] [Abstract][Full Text] [Related]
5. The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception.
Moon SW; Park EH; Suh HR; Ko DH; Kim YI; Han HC
Brain Res; 2016 Oct; 1648(Pt A):11-18. PubMed ID: 27378583
[TBL] [Abstract][Full Text] [Related]
6. U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages.
Chao CC; Gekker G; Sheng WS; Hu S; Peterson PK
Drug Alcohol Depend; 2001 Apr; 62(2):149-54. PubMed ID: 11245971
[TBL] [Abstract][Full Text] [Related]
7. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
8. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
[TBL] [Abstract][Full Text] [Related]
9. Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.
Sullivan LC; Chavera TA; Gao X; Pando MM; Berg KA
J Pharmacol Exp Ther; 2017 Jul; 362(1):200-209. PubMed ID: 28465374
[TBL] [Abstract][Full Text] [Related]
10. Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.
Jacobs BA; Pando MM; Jennings EM; Jamshidi RJ; Zamora JC; Chavera TS; Clarke WP; Berg KA
Neuropharmacology; 2019 Jun; 151():208-218. PubMed ID: 30776373
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.
Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y
Cells; 2021 Oct; 10(10):. PubMed ID: 34685631
[TBL] [Abstract][Full Text] [Related]
12. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates.
Belanger S; Ma W; Chabot JG; Quirion R
Neuroscience; 2002; 115(2):441-53. PubMed ID: 12421610
[TBL] [Abstract][Full Text] [Related]
13. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.
Berg KA; Rowan MP; Gupta A; Sanchez TA; Silva M; Gomes I; McGuire BA; Portoghese PS; Hargreaves KM; Devi LA; Clarke WP
Mol Pharmacol; 2012 Feb; 81(2):264-72. PubMed ID: 22072818
[TBL] [Abstract][Full Text] [Related]
14. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
Zhang WM; Wu S; Yu XC; Wang HX; Bian JS; Wong TM
J Mol Cell Cardiol; 1999 Feb; 31(2):355-62. PubMed ID: 10093048
[TBL] [Abstract][Full Text] [Related]
15. Nonopioid actions of U50,488 enantiomers contribute to their peripheral cutaneous antinociceptive effects.
Joshi SK; Gebhart GF
J Pharmacol Exp Ther; 2003 Jun; 305(3):919-24. PubMed ID: 12626643
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
18. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.
Lawson KP; Nag S; Thompson AD; Mokha SS
Pain; 2010 Dec; 151(3):806-815. PubMed ID: 20926192
[TBL] [Abstract][Full Text] [Related]
19. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
